People: Insys Therapeutics Inc (INSY.OQ)
Dr. Larry Dillaha, M.D., is Chief Medical Officer of Insys Therapeutics, Inc. Prior to joining the company, he served as Executive Vice-President and Chief Medical Officer for Shionogi (formerly Sciele Pharma, Inc. and First Horizon Pharmaceutical Corp.) from 2006 to 2010. While at Shionogi/Sciele, Dr. Dillaha oversaw the development and FDA of numerous compounds integral to the success of the company. He has experience interacting with the FDA and designing drug development plans. Prior to serving as an officer of Sciele, Dr. Dillaha served as Medical Director for Sanofi, a multinational pharmaceutical company, where he was involved in several clinical studies for the company’s lead compounds. Dr. Dillaha also serves as a member of the board of directors of New Haven Pharma, Inc, a pharmaceutical company. Dr. Dillaha earned his M.D. degree as well as a B.A. in Biology from the University of Tennessee.
|Total Annual Compensation, USD||Long-Term Incentive Plans, USD||All Other, USD||Fiscal Year Total, USD|